Back
Intuitive Surgical Quote, Financials, Valuation and Earnings
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Buy
69
ISRG
Intuitive Surgical
Last Price:
375.26
Seasonality Move:
14.94%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Intuitive Surgical Price Quote
$375.26
-0.07 (0.57%)
(Updated: April 27, 2024 at 6:09 AM ET)
Intuitive Surgical Key Stats
Buy
69
Intuitive Surgical (ISRG)
is a Buy
Day range:
$368.10 - $377.83
52-week range:
$254.85 - $403.76
Dividend yield:
0%
P/E ratio:
74.62
P/S ratio:
18.39
P/B ratio:
9.53%
Volume:
927.5K
Avg. volume:
1.6M
1-year change:
27.25%
Market cap:
$133.1B
Revenue:
$7.1B
EPS:
$5.54
How Much Does Intuitive Surgical Make?
-
How Much Are Intuitive Surgical's Sales Annually?
ISRG Revenues are $7.1B -
How Much Profit Does Intuitive Surgical's Make A Year?
ISRG net income is $1.8B
Is Intuitive Surgical Growing As A Company?
-
What Is Intuitive Surgical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Intuitive Surgical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.51%
Intuitive Surgical Stock Price Performance
-
Did Intuitive Surgical Stock Go Up Last Month?
Intuitive Surgical share price went down by -5.61% last month -
Did ISRG's Share Price Rise Over The Last Year?
ISRG share price rose by 27.25% over the past 1 year
What Is Intuitive Surgical 52-Week High & Low?
-
What Is Intuitive Surgical’s 52-Week High Share Price?
Intuitive Surgical has traded as high as $403.76 over the past 52 weeks -
What Is Intuitive Surgical’s 52-Week Low Share Price?
Intuitive Surgical has traded as low as $254.85 over the past 52 weeks
Intuitive Surgical Price To Free Cash Flow
-
Is Intuitive Surgical Stock Overvalued?
Intuitive Surgical is trading at a price to free cash flow ratio of 225.89 -
Is Intuitive Surgical Stock Undervalued?
Intuitive Surgical EV to Free Cash Flow ratio is 215.53 -
What Is Intuitive Surgical’s Price Earnings Growth Ratio?
ISRG PEG ratio is 1.32 -
Is Intuitive Surgical Trading At A Premium To Earnings?
Intuitive Surgical EV to EBIT ratio is 69.47
Is It Risky To Buy Intuitive Surgical?
-
How Much Debt Does Intuitive Surgical Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intuitive Surgical Have?
Cash and short term investments quarterly total is $4.8B -
What Is Intuitive Surgical’s Book Value Per Share?
Book value per share is 39.36
Is Intuitive Surgical Cash Flow Positive?
-
What Is ISRG Cash Flow From Operations?
Cash flow from operations (TTM) is $1.7B -
What Is Intuitive Surgical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $46.9M -
What Is Intuitive Surgical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.1B
Intuitive Surgical Return On Invested Capital
-
Is Management Doing A Good Job?
ISRG return on invested capital is 15.7% -
What Is Intuitive Surgical Return On Assets?
ROA measures how assets are converting to revenues and is 13.63% -
What Is ISRG Return On Equity?
ROE is a measure of profitability and is 15.7%
Intuitive Surgical Earnings Date & Stock Price
-
What Is Intuitive Surgical's Stock Price Today?
A single share of ISRG can be purchased today for 375.33 -
What Is Intuitive Surgical’s Stock Symbol?
Intuitive Surgical trades on the S&P500 under the ticker symbol: ISRG -
When Is Intuitive Surgical’s Next Earnings Date?
The next quarterly earnings date for Intuitive Surgical is scheduled on July 19, 2024 -
When Is ISRG's next ex-dividend date?
Intuitive Surgical's next ex-dividend date is May 26, 2020 -
How To Buy Intuitive Surgical Stock?
You can buy Intuitive Surgical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intuitive Surgical Competitors
-
Who Are Intuitive Surgical's Competitors?
Below is a list of companies who compete with Intuitive Surgical or are related in some way:
Intuitive Surgical Dividend Yield
Data Unavailable
Intuitive Surgical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 51% | 5.98% |
| Revenue: | 11.46% | 1.05% |
Analyst Recommendations
| Buy Recommendations: | 13 |
|---|---|
| Hold Recommendations: | 9 |
| Sell Recommendations: | 0 |
| Price Target: | 420.28 |
| Upside from Last Price: | 11.98% |